ClinicalTrialsFinder
RecruitingNot ApplicableNCT07040618

Rhomboid Intercostal Block vs Erector Spinae Block

Assessing the Effectiveness of Rhomboid Intercostal and Erector Spinae Plane Blocks After Lung Cancer Thoracotomy

Sponsor

Cairo University

Enrollment

60 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Lung Cancer

Summary

This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of nerve blocks used to manage pain after chest surgery (thoracotomy) for lung cancer: the Rhomboid Intercostal Block and the Erector Spinae Block. Both are injections of local anesthetic near specific muscles in the back. The goal is to find out which technique provides better pain relief after surgery. **You may be eligible if...** - You are between 18 and 65 years old - You are scheduled for thoracotomy (chest surgery) for lung cancer - Your BMI is between 20 and 35 - You are in generally good pre-surgical health (ASA status II or III) - You are willing and able to give consent **You may NOT be eligible if...** - You are under 18 or over 65 years old - Your BMI is below 20 or above 35 - You have a known allergy to local anesthetics or opioids used in the study - You have a history of chronic pain or psychological disorders - You are classified as high surgical risk (ASA status IV) - You decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUltrasound-guided Rhomboid Intercostal Block

This intervention involves an ultrasound-guided injection of 20-25 mL of 0.25% bupivacaine into the fascial plane between the rhomboid major and intercostal muscles. The patient is positioned laterally, and the block is performed at the T5-T6 level using a high-frequency linear ultrasound probe. The goal is to anesthetize the lateral cutaneous branches of the intercostal nerves to provide postoperative thoracic analgesia.

PROCEDUREUltrasound-guided Erector Spinae Plane Block

This intervention consists of an ultrasound-guided injection of 20-25 mL of 0.25% bupivacaine into the plane deep to the erector spinae muscle at the T4-T5 transverse process level. The patient is positioned sitting or in lateral decubitus, and the procedure uses a curved or linear ultrasound probe. This block targets the dorsal and ventral rami of thoracic spinal nerves to manage postoperative pain after thoracotomy.

Locations(1)

National Cancer Institute - Cairo University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07040618

Related Trials

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT000018231 location

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

NCT014876031 location

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

NCT051188542 locations

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

NCT024217181 location

Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules

NCT053069121 location